Takeda Pharmaceutical Company Limited
NYSETAK short interest surges 26.4% over one week to 3.79M shares, highest level since early September amid insider selling and rising cost-to-borrow.
No long-form analysis yet for TAK. Pulse alerts and the live data picture are available on ORTEX.
Open TAK on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TAK — free to start on ORTEX.
Sign up for free →Open TAK on ORTEXSnapshot as of 22 Sept 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live TAK data →